div class=trans-pagebuttonPage 1button div class=trans-image a href=https:reader039fdokumencomreader039viewer2023042621633570272670d310da0f1a89html5page1jpg target=_blank amp-img class=trans-thumb alt=Page 1: Reduced Capacity of Antibodies from Patients Infected with Human Immunodeficiency Virus Type 1 HIV1 Group O to Neutralize Primary Isolates of HIV1 Group M Viruses src=https:reader039fdokumencomreader039viewer2023042621633570272670d310da0f1a89html5thumbnails1jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 2button div class=trans-image a href=https:reader039fdokumencomreader039viewer2023042621633570272670d310da0f1a89html5page2jpg target=_blank amp-img class=trans-thumb alt=Page 2: Reduced Capacity of Antibodies from Patients Infected with Human Immunodeficiency Virus Type 1 HIV1 Group O to Neutralize Primary Isolates of HIV1 Group M Viruses src=https:reader039fdokumencomreader039viewer2023042621633570272670d310da0f1a89html5thumbnails2jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 3button div class=trans-image a href=https:reader039fdokumencomreader039viewer2023042621633570272670d310da0f1a89html5page3jpg target=_blank amp-img class=trans-thumb alt=Page 3: Reduced Capacity of Antibodies from Patients Infected with Human Immunodeficiency Virus Type 1 HIV1 Group O to Neutralize Primary Isolates of HIV1 Group M Viruses src=https:reader039fdokumencomreader039viewer2023042621633570272670d310da0f1a89html5thumbnails3jpg width=142 height=106 layout=responsive amp-imga divdivdiv class=trans-pagebuttonPage 4button div class=trans-image a href=https:reader039fdokumencomreader039viewer2023042621633570272670d310da0f1a89html5page4jpg target=_blank amp-img class=trans-thumb alt=Page 4: Reduced Capacity of Antibodies from Patients Infected with Human Immunodeficiency Virus Type 1 HIV1 Group O to Neutralize Primary Isolates of HIV1 Group M Viruses...